Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Ligand Pharm
(NQ:
LGND
)
142.62
USD
+7.73 (+5.73%)
Official Closing Price
Updated: 7:44 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Ligand Pharm
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Noteworthy Friday Option Activity: VRTX, SPLK, LGND
January 22, 2021
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Vertex Pharmaceuticals, Inc. (VRTX), where a total of 8,133 contracts have traded so far,...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
BIVI
CLLS
ORGO
From
Benzinga
Ligand Pharmaceuticals Trying To Close In On Key Technical Benchmark
January 21, 2021
Ligand Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PASG
JNJ
STOK
From
Benzinga
Top-Rated Stocks: Ligand Pharmaceuticals Sees Composite Rating Climb To 97
January 20, 2021
On Wednesday, Ligand Pharmaceuticals got an upgrade for its IBD SmartSelect Composite Rating from 93 to 97.
From
Investor's Business Daily
Growth Stocks To Watch: These Three Leaders Score Breakouts From Buy Points
January 19, 2021
Three top growth stocks including CarMax, Ligand Pharmaceuticals and Vertiv Holdings broke out Tuesday and hit new highs.
From
Investor's Business Daily
Stocks Close Higher, Near Day's Highs; Solar Stocks Extend Rally
January 19, 2021
A rebounding stock market closed near session highs Tuesday, as the S&P 500 and Dow Jones Industrial Average appeared to get through a key test.
From
Investor's Business Daily
The Best Dressed Chart Patterns Of 2020 - Part I
January 03, 2021
Our goal for the year was simple: Identify and trade the best-looking classical chart set-ups. We've broken it into sections by chart pattern and the best set-ups in those patterns.
Tags
Currencies/Forex
Stocks / Equities
Futures
From
Blogs - TalkMarkets
Notable Thursday Option Activity: FLGT, LGND, DBX
December 31, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Fulgent Genetics Inc (FLGT), where a total of 7,997 contracts have traded so far,...
Tags
Stocks
From
Market News Video
Analysts Predict 12% Upside For The Holdings of FTHI
December 28, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
20 best mid-cap stocks for 2021, according to analysts
December 17, 2020
Companies including Ligand Pharmaceuticals and LendingTree are expected by analysts to post double-digit revenue growth next year.
Tags
TPH
TMHC
LGND
From
MarketWatch
Noteworthy Monday Option Activity: RUBY, LGND, FIXX
December 14, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rubius Therapeutics Inc (RUBY), where a total volume of 9,633 contracts has been...
Tags
Stocks
From
Market News Video
Noteworthy Friday Option Activity: LGND, MGNI, MAN
November 27, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Ligand Pharmaceuticals Inc (LGND), where a total volume of 1,541 contracts has been...
Tags
Stocks
From
Market News Video
Land This Bargain Even Cheaper Than Director Patel Did
November 09, 2020
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 2, Ligand Pharmaceuticals Inc's Director, Sunil...
Tags
Stocks
From
Market News Video
Recap: Ligand Pharmaceuticals Q3 Earnings
October 30, 2020
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) were flatin pre-market trading after the company reported Q3 ...
Tags
Market News
LGND
News
From
Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AXGT
EQ
IMNM
From
Benzinga
Earnings Scheduled For October 30, 2020
October 30, 2020
Companies Reporting Before The Bell • Pinnacle West Capital (NYSE:PNW) is estimated to report quarterly earnings at ...
Tags
GT
ABR
Earnings
From
Benzinga
Notable Wednesday Option Activity: EIGI, GOOG, LGND
October 28, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Endurance International Group Holdings Inc (EIGI), where a total volume of 6,163...
Tags
Stocks
From
Market News Video
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
October 25, 2020
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and ...
Tags
EXAS
NUVA
ABMD
From
Benzinga
FDA Approves Gilead's Remdesivir For Treatment Of Hospitalized COVID-19 Patients
October 22, 2020
The U.S. Food and Drug Administration has approved the antiviral Veklury, commonly known as remdesivir, for the treatment of ...
Tags
LGND
Captisol
Market News
From
Benzinga
Why the time is right for a bet on Caesars and 2 other unloved stocks, says this fourth-generation money manager
October 22, 2020
Our call of the day comes from a fourth-generation money manager who specializes in finding overlooked smaller companies.
Tags
LGND
TSLA
NASDAQ 100 FUTURES
From
MarketWatch
Notable Tuesday Option Activity: ACI, LGND, COUP
October 20, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Albertsons Companies Inc (ACI), where a total volume of 16,547 contracts has been...
Tags
Stocks
From
Market News Video
Analysts Anticipate AFSM To Hit $21
October 20, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal
October 17, 2020
Curon Biopharma, a Shanghai clinical-stage in-licensing company, acquired China rights to Tenalisib, a dual PI3K delta and gamma inhibitor, from Rhizen Pharma. Rhizen will receive milestone payments...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Week in Review: Curon Bio Acquires Lymphoma Drug Rights in $150 Million Deal
October 17, 2020
Deals and Financings Shanghai Curon Biopharma acquired China rights to a treatment for a novel lymphoma from Rhizen Pharma of Switzerland in a $149.5 million deal; EdiGene of Beijing raised $67 million...
From
ChinaBio® Today
Week in Review: Curon Bio Acquires Rights to Lymphoma Drug in $150 Million Deal
October 17, 2020
Deals and Financings Shanghai Curon Biopharma acquired China rights to a treatment for a novel lymphoma drug from Rhizen Pharma of Switzerland in a $149.5 million deal; EdiGene of Beijing raised $67...
From
ChinaBio® Today
HitGen Pays $25 Million to Acquire Vernalis, a UK Discovery CRO, from Ligand
October 12, 2020
HitGen will acquire Vernalis Limited, a Cambridge , UK CRO, from Ligand Pharma for $25 million. HitGen, a Chengdu small molecule drug development CRO, said its operations are a good fit with Vernalis'...
From
ChinaBio® Today
Ligand: The Small Cap Powering Gilead's Remdesivir
October 05, 2020
President Donald Trump has taken several treatments to combat the coronavirus diagnosis he received last week. Among them are an ...
Tags
Donald Trump
Benzinga
Small Cap Analysis
From
Benzinga
Analyst Favorites With Strong Buyback Activity: Ligand Pharmaceuticals Ranks As a Top Pick
October 02, 2020
A study of analyst recommendations at the major brokerages shows that Ligand Pharmaceuticals Inc (LGND) is the #64 broker analyst pick among those stocks screened by The Online Investor for strong...
Tags
Stocks
From
Market News Video
10 Biggest Price Target Changes For Tuesday
September 29, 2020
Morgan Stanley lifted the price target on Equinix, Inc. (NASDAQ: EQIX) from $670 to $712. Equinix shares rose 1.8% to close at ...
Tags
NXPI
Biotechnology
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.